Humana Inc: Form 10-Q for the period ended Mar 31, 2012
Filed with the SEC on Apr 30, 2012 and accepted by EDGAR at Apr 30, 2012, 16:39 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2012-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2012-01-01 to 2012-03-31 | $10.22bn | us-gaap:Revenues |
| Selling, general and administrative | 3 months2012-01-01 to 2012-03-31 | $1.38bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2012-01-01 to 2012-03-31 | $416.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2012-01-01 to 2012-03-31 | $26.0m | us-gaap:InterestExpense |
| Income tax | 3 months2012-01-01 to 2012-03-31 | $142.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2012-01-01 to 2012-03-31 | $248.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2012-01-01 to 2012-03-31 | $1.49 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2012-01-01 to 2012-03-31 | $1.51 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2012-01-01 to 2012-03-31 | 166,088,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2012-01-01 to 2012-03-31 | $2.35bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2012-01-01 to 2012-03-31 | $86.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months2012-01-01 to 2012-03-31 | $41.0m | us-gaap:PaymentsOfDividends |
| Share repurchases | 3 months2012-01-01 to 2012-03-31 | $151.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2012-03-31 | $3.66bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2012-03-31 | $14.06bn | us-gaap:AssetsCurrent |
| Total assets | At period end2012-03-31 | $20.70bn | us-gaap:Assets |
| Current liabilities | At period end2012-03-31 | $8.82bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2012-03-31 | $12.47bn | us-gaap:Liabilities |
| Long-term debt | At period end2012-03-31 | $1.62bn | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2012-03-31 | $8.23bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2012-03-31 | 163,179,240 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001193125-12-196253. Last ingested by Listed: Nov 10, 2026, 18:12 ET. Listed shows no prices and gives no investment advice.